Features Suggestive of Ovulation After Induction

1. Urinary LH Surge (LH Kit Testing)

• The LH surge is detectable in urine approximately 2 hours after the serum LH peak.
• Commercially available ELISA-based urinary LH kits use a threshold of 35–50 mIU/mL.
• When the LH surge is detected, ovulation may occur within the next 48 hours.
• Positive predictive value: 92%; negative predictive value: 95%.
• After clomiphene or letrozole (days 5–9), the LH surge typically occurs on cycle days 16–17.
• LH kit testing should begin when the largest ultrasound-measured follicle reaches 14 mm in diameter.
• Testing twice daily may improve detection (the surge may last <12 hours).

2. Midluteal Serum Progesterone

• Should be measured 7 days after the LH surge (or on days 21–23 of a 28-day cycle) to coincide with peak progesterone secretion.
• A level >3 ng/mL (>10 nmol/L) typically confirms ovulation.
• Ovulatory levels are often considerably higher than 3 ng/mL.
• Note: Low midluteal progesterone alone does not necessarily confirm anovulation, due to pulsatile secretion.

3. Ultrasound (US) Monitoring — Most Reliable

• Ovulation is characterized by:
  • Decrease in follicle size (follicle collapse)
  • Appearance of fluid in the cul-de-sac (peritoneal fluid post-rupture)
• Following ovulation induction, follicles typically reach a preovulatory diameter of 19–25 mm (may be as large as 30 mm), compared with 17–19 mm in spontaneous cycles.
• If a dominant follicle is present without a spontaneous LH surge, hCG can be administered to trigger final follicular maturation — ovulation occurs approximately 40 hours later.
• If large cysts are seen at baseline, the current treatment cycle should be withheld.
• A luteinized unruptured follicle (LUF) can occur in ~10% of normally fertile women and ~25% in unexplained infertility — progesterone rises normally without visible follicle rupture on US.

4. Combined LH + Ultrasound Monitoring

• Start LH kit testing when the largest US follicle reaches 14 mm.
• Confirm ovulation by midluteal progesterone 7 days after the LH surge.
• This combined approach is the most comprehensive monitoring strategy.

Summary Table

Clinical Features of Ovulation

1. Mittelschmerz (Mid-cycle Pain)

• A variable amount of lower abdominal pain occurring at mid-cycle, around the time of ovulation.
• Caused by:
  • Slight bleeding into the peritoneal cavity following follicle rupture
  • Enlargement of the oocyte just before ovulation
• The pain is typically sudden and constant, felt in one iliac fossa.
• Considered a secondary indicator of ovulation — useful but not definitive.
• — The Developing Human: Clinically Oriented Embryology

2. Cervical Mucus Changes

• Under estrogen influence at mid-cycle, cervical mucus undergoes characteristic changes:
  • Becomes thin, watery, copious, clear, and alkaline — favoring sperm penetration.
  • Spinnbarkeit increases markedly: a drop can be stretched into a thin thread 8–12 cm or more in length.
  • When spread on a slide and dried, produces an arborizing fern-like pattern (ferning/arborization).
  • Channels form in the mucus, creating openings in the cervix through which sperm are propelled.
• After ovulation, under progesterone influence, mucus becomes thick, tenacious, cellular, and non-elastic, and no longer ferning.
• — Ganong's Review of Medical Physiology; Costanzo Physiology

3. Basal Body Temperature (BBT) Rise

• A rise in BBT of at least 0.1°C (about 0.2–0.5°F) indicates ovulation has occurred.
• The rise is due to the thermogenic effect of progesterone secreted by the newly formed corpus luteum.
• The temperature shift is sustained through the luteal phase and drops with menstruation.
• Considered a primary indicator of ovulation.
• — The Developing Human; Swanson's Family Medicine Review

4. LH Surge (Biochemical-Clinical Correlate)

• A mid-cycle LH surge triggers ovulation within ~36–48 hours.
• Detectable in urine ~2 hours after the serum peak using commercially available kits.
• Clear, stretchy cervical mucus and mild pelvic discomfort often coincide with this surge.

5. Vaginal Cytology Changes

• Under estrogen influence (follicular phase / around ovulation): vaginal epithelium becomes cornified; cornified cells are identifiable on vaginal smear.
• After ovulation, under progesterone: thick mucus is secreted, epithelium proliferates, and becomes infiltrated with leukocytes.
• — Ganong's Review of Medical Physiology

6. Breast Changes

• Many women experience breast swelling, tenderness, and pain premenstrually, reflecting estrogen (ductal proliferation) and progesterone (lobular/alveolar growth) effects that peak around ovulation and the luteal phase.
• — Ganong's Review of Medical Physiology

7. Ultrasound Features (Objective Confirmation)

• Pre-ovulatory follicle reaches 17–19 mm in spontaneous cycles (19–25 mm in induced cycles).
• Ovulation is confirmed by:
  • Sudden decrease in follicle size (collapse)
  • Free fluid in the pouch of Douglas (cul-de-sac)

Summary

Clinical Scenario

Diagnosis: Hypogonadotropic Hypogonadism / Functional Hypothalamic Anovulation

• Nutritional deficits and caloric restriction → decreased GnRH pulsatility
• → ↓ FSH and LH → anovulation/oligovulation
• This is classified as WHO Group I anovulation (hypogonadotropic hypoestrogenic)

Best Advice for the Couple

First-line and Most Important: Weight Gain

"Lifestyle modifications should be recommended in patients with low BMI." — Harrison's Principles of Internal Medicine, 22e

"Being underweight (BMI < 19) increases time to conception 4-fold." — Kaplan & Sadock's Comprehensive Textbook of Psychiatry

• Weight gain to a BMI ≥ 18.5 is the single most important and first-line intervention.
• Correcting the energy deficit often restores spontaneous GnRH pulsatility and spontaneous ovulation without any pharmacological treatment.
• The term "functional" in functional hypothalamic anovulation specifically implies that correcting the underlying behavioral/nutritional cause reverses the ovulatory dysfunction.
• Conception after weight restoration is associated with better pregnancy outcomes — ovulation induction in low-weight women carries risks of premature labour and intrauterine growth retardation (IUGR).

Why NOT to Jump to Ovulation Induction First

1. It does not correct the underlying metabolic derangement.
2. It does not restore bone mineral density (these women are also at risk of osteoporosis).
3. Pregnancy in a severely underweight woman risks preterm labour, IUGR, and fetal neuropsychological compromise (due to concomitant euthyroid sick syndrome/hypercortisolaemia).
4. It may mask ongoing psychological/nutritional dysfunction.

Evaluate for Underlying Cause of Low Weight

• Screen for anorexia nervosa / eating disorder (amenorrhea occurs in 66–84% of anorexia patients).
• Screen for female athlete triad (relative energy deficiency in sport).
• Screen for psychosocial stressors.
• If an eating disorder is identified → specialized psychiatric/nutritional treatment is indicated first.

Additional General Preconception Advice

• Time intercourse every 1–2 days during the fertile window (5–6 days prior to ovulation).
• Folic acid supplementation.
• Avoid smoking (increases infertility risk by 60%) and limit caffeine (≤2 cups/day).
• Monitor BBT or use urinary LH kits once menstrual cycles resume after weight restoration.

If Weight Restoration Fails to Restore Ovulation

• Ovulation induction with letrozole or clomiphene citrate (first-line oral agents)
• Followed by injectable gonadotropins if oral agents fail
• Pulsatile GnRH therapy is the most physiological option for hypogonadotropic anovulation

Summary Answer

The best advice is weight gain to a BMI ≥ 18.5. This is the primary, first-line treatment. Pharmacological ovulation induction should only be considered after weight restoration, and even then, the risks of pregnancy at low weight must be discussed. Screening for an eating disorder is mandatory.